Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease

International Journal of Cardiovascular Interventions

Volumn 7, Issue 3, 2005, Pages 122-125

  Kornowski, Ran ^a   Vaknin Assa, Hana ^b   Assali, Abid ^b   Fuchs, Shmuel ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Angioplasty; Atherosclerosis; Coronary artery disease; Stents

Indexed keywords

CYPHER; RAPAMYCIN;

ANGINA PECTORIS; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LUNG EMBOLISM; MEDICAL EXAMINATION; PATIENT INFORMATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SUDDEN DEATH; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERIOSCLEROSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 27144545021     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500306875     Document Type: Review

References (13)

1. Morice MC, Serruys PW, Sousa JE, et al. RAVEL Study Group., A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
2. Moses JW, Leon MB, Popma JJ, et al. SIRIUS Investigators., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
3. Ardissino D, Cavallini C, Bramucci E, et al. SES-SMART Investigators., Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA. 2004;292:2727-34.
4. Arampatzis CA, Hoye A, Lemos PA, et al. Elective sirolimus-eluting stent implantation for multi-vessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients-the Rotterdam experience. Catheter Cardiovasc Interv. 2004;63:57-6.
5. Serruys PW, et al. The Arterial Revascularization Therapy Study II (ARTS II) Results. American College of Cardiology Annual Meeting. Orlando, FL; 6 March 2005.
6. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol. 2004;43:1154-60.
7. Kornowski R, Lansky AJ. Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease. Catheter Cardiovasc Interv. 2000; 50:245-54.
8. Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation. 1999;99:847-51.
9. Serruys PW, Unger F, Sousa JE, et al. Arterial Revascularization Therapies Study Group., Comparison of coronary-artery bypass surgery and stenting for the treatment of multi-vessel disease. N Engl J Med. 2001; 344:1117-24.
10. Kornowski R, Mehran R, Satler LF, et al. Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol. 1999;33:420-6.
11. Laham RJ, Ho KK, Baim DS, et al. Multi-vessel Palmaz-Schatz stenting: early results and one-year outcome. J Am Coll Cardiol. 1997;30:180-5.
12. Mehran R, Dangas GD, Kobayashi Y, et al. Short- and long-term results after multi-vessel stenting in diabetic patients. J Am Coll Cardiol. 2004;43:1348-54.
13. Reynolds MR, Neil N, Ho KK, et al. Clinical and economic outcomes of multi-vessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J. 2003;145:334-42.